Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more
Scientific production - Institute for Cancer Research
Award ceremony May 25thOslo University Hospital awards 6 excellent articles for the second half-year of 2017
In order to stimulate excellent research and draw attention to the hospital's extensive research activity, Oslo University Hospital reward outstanding publications regularly.
Six research groups were awarded for their excellent papers published during the second half-year of 2017 on May 25th in the large auditorium at Ullevål sykehus. Each group received NOK 50.000 for use in further research. The prize winners gave short presentations of the main findings in their respective articles.
Paper from Selbo’s project group featured on the cover of Photochemical & Photobiological Sciences
The paper entitled “Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins” by Marius S. Eng et al. was a joint academic-industry effort including collaboration with the Ferronel lab at Massachusetts General Hospital/Harvard Medical School, the Rosenblum lab at MD Anderson Cancer Center, the Mælandsmo lab at Oslo University Hospital (OUS), the Imaging Facility at the Institute for Cancer Research (OUS) and PCI Biotech. The manuscript was published in the May issue of Photochemical & Photobiological Sciences (The Royal Society of Chemistry), which is a society-owned journal publishing high quality research on all aspects of photochemistry and photobiology.
Theodossiou and Berg presented in national media after receiving prestigious EU grant
Theodossis Theodossiou and Kristian Berg from the Photochemical internalisation (PCI) group at the Department of Radiation Biology at the Institute for Cancer Research have been funded by the Future and Emerging Technology (FET) program under the Excellent Science section of the Horizon 2020. The FET program funded 11 projects out of 820 grant applications (1,4 % success rate) and the proposal by Theodossiou and Berg was rated as number 6. The project is designed to develop treatment of aggressive brain tumors such as glioblastoma multiforme (GBM). The major national newspaper VG recently (May 3rd) published a feature article about the supported project, entitled "Pioneering Norwegian technology: aiming to kill aggressive brain tumors by producing light in the brain."
Updated:King Olav V´s Cancer Research Prize for 2018 to Vessela Kristensen
King Olav V's cancer research award for 2018 went to professor Vessela Kristensen, head of the Cancer Genome Variation Group at the Department of Cancer Genetics at the Institute for Cancer Research.
The prestigious prize was handed over by HM Kong Harald V on behalf of the Norwegian Cancer Society in Oslo on April 16th.
New: The Norwegian Cancer Society has recently published a feature article about Vessela Kristensen and her research.
European Research Council Advanced Grant to Stenmark for the second time
Professor Harald Stenmark, head of the "Cellular membrane dynamics" group at the Department of Molecular Cell Biology, receives ERC Advanced Grant for the second time. Only two other Norwegian researchers, Professor Edvard Moser (NTNU) and Professor Kenneth Hugdahl (UiB), have received ERC Advanced Grant twice in their careers.
The research project "Coincidence detection of proteins and lipids in regulation of cellular membrane dynamics (CODE)" will last for five years and has been awarded 2.5 million Euro.
Mini symposium Cancer Genomics, April 17th, 10am-4pmOn the occasion of King Olav V's award to Professor Vessela N. Kristensen
On the occasion of King Olav V's award 2018 to professor Vessela N. Kristensen there will be held a mini symposium on cancer genomics April 17th at 10am-4pm in the Auditorium at the Institute for Cancer Research, in the K building at Montebello. Speakers are prominent scientists Olga Troyanskaya, Charles Vaske, Sampsa Hautanemi, Diether Lambrechts, Gyan Bhanot, Peter Fasching and Zohar Yakhini.
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research